Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by malibukion Dec 15, 2016 9:34am
96 Views
Post# 25603467

changre request

changre request
I do not agree the arguement that asking for sth solid would not change anything. There are 4 possbile scenarios

- They can not disclose any detail due to their agreements.

-They may disclose somethiing but this could harm the deal

- They may disclose some stuff that would not harm negotiations but would not do so because there is not any demand. (At least confirmation of more than one sheet receipt can be OK wthout giving any price or name.)

- They share sth more solid with binding agreement or more data of their further analysis. This could be hard.

By saying making pressure would not change anything you directly disccard the last two options and only take the first two granted. Sticking the first scenoario is more comfortable for them. They do not need to think and spend more time  for shareholders. They would defintely be happy with doing nothing.

We already have almost zero solid information. So asking for that would not harm the current situation and if we get sth this is a gain. I think fear, risk - reward etc is obivious for all. I am just pointing the elephant in the room.

I have nothing against with the pipeline and I have similar conclusions.

I do not consider to accumulate more as I have already assigned most of my investment here.

PS. I got a response from them that my request for the term sheet receipt public disclosure would be evaluated (does not mean yes or no). So it does not seem too useless to ask for sth, does it?

GL
M



Bullboard Posts